Veterinary CRO & CDMO Market Trends Highlight Strong Growth in Medicine and Medical Device Development Services

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Veterinary CRO & CDMO Market - (By Animal Type (Companion, Livestock Animals), By Application Type (Medicine, Medical Devices), By Service Type (Discovery, Development, Manufacturing, Packaging & Labelling, Market Approval & Post-Marketing)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

According to the latest research by InsightAce Analytic, the Global Veterinary CRO & CDMO Market is expected to grow with a CAGR of 55.2% during the forecast period of 2025-2034.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2333

The veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) market comprises specialized service providers that support the animal health industry in the research, development, and production of veterinary pharmaceuticals, vaccines, and related products. Veterinary CROs deliver a range of services-including regulatory consulting, preclinical and clinical trial management-aimed at ensuring the safety, efficacy, and regulatory compliance of animal health products.

Veterinary CDMOs focus on the development, formulation, and manufacturing of veterinary drugs and vaccines, offering scalable production solutions while adhering to stringent regulatory standards. Several organizations operate exclusively within the animal health domain, intensifying market competition. These entities frequently collaborate with biotechnology firms, pharmaceutical companies, and animal health enterprises to meet growing demands.

Market expansion is being driven by the rise in companion animal ownership and increased awareness of pet healthcare. The discovery of novel therapeutic agents and treatment options for animals such as dogs, cats, and horses has further stimulated demand for specialized veterinary research and manufacturing services. In addition, the trend toward outsourcing R&D functions is gaining momentum as pharmaceutical and biotech companies seek to reduce operational costs and enhance efficiency. Increasing regulatory scrutiny and the need to demonstrate product safety and efficacy are prompting firms to engage CROs and CDMOs with deep domain expertise, thereby contributing to the sector's continued growth.

List of Prominent Players in the Veterinary CRO & CDMO Market:
• Labcorp Drug Development
• Charles River Laboratories
• Clinvet
• Klifovet GmbH
• Oncovet Clinical Research (OCR)
• Knoell Triveritasm
• Vetspin,
• Inotiv
• Idexx Laboratories
• Zoetis Nexvet
• PAREXEL International Corporation
• ICON plc
• Pharmaceutical Product Development, LLC (PPD)
• Syneos Health
• WuXi AppTec
• Medpace
• Envigo
• Vetio Animal Health
• Clinipace
• MPI Research
• Veterinary Research Management (VRM)
• VetPharm, Inc.
• Merck Animal Health
• others.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
The veterinary Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) market is propelled by several key factors. The increasing demand for advanced veterinary pharmaceuticals and therapeutic solutions, coupled with the rising incidence of animal diseases, is significantly boosting the need for specialized CRO and CDMO services. Additionally, the veterinary pharmaceutical sector's growing focus on research and development has heightened the demand for the technical expertise and infrastructure that these service providers offer. Furthermore, the globalization of veterinary drug development and manufacturing-along with the necessity to meet stringent regulatory standards-is further contributing to market growth.

Challenges:
Despite strong growth potential, the market faces certain constraints. The substantial cost associated with outsourcing to CROs and CDMOs can present a challenge, particularly for small and mid-sized enterprises with limited financial resources. Moreover, the complex and varying regulatory requirements across different regions pose significant operational hurdles and can restrict global market penetration. A further limitation is the lack of widespread awareness and understanding of the strategic benefits offered by CRO and CDMO services among some veterinary pharmaceutical stakeholders, which may hinder broader market adoption.

Regional Trends:
North America is anticipated to maintain the largest share of the global veterinary CRO and CDMO market throughout the forecast period. The region benefits from a well-established veterinary healthcare infrastructure, high levels of awareness, and a concentration of pharmaceutical companies and research institutions. Stringent regulatory environments and rigorous compliance standards are key drivers for outsourcing specialized services. In addition, the region's large pet-owning population and strong livestock sector further support the demand for veterinary pharmaceuticals and research-related services.

Conversely, the Asia-Pacific region is projected to witness the fastest growth in this market. The increasing population of companion animals and livestock in countries such as China and India has created a robust demand for veterinary medicines and healthcare products. Rising pet ownership trends and expanding awareness of animal health have accelerated the need for veterinary services, making the region a critical growth frontier for CRO and CDMO providers.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2333

Recent Developments:
• In April 2022, Clinical validation of a next-generation sequencing-based multi-cancer detection 'liquid biopsy' blood test in over 1,000 canines using an independent testing set: The CANcer Detection in canines was a clinical investigation funded by PetDx. Assessing the efficacy of a novel multi-cancer blood test in identifying and classifying cancer in canines was the objective of this clinical investigation.
• In January 2022, Covetrus, a global leader in animal health technology and services, has announced the release of Covetrus Pulse, an innovative cloud-based veterinary operating system (vOS) that easily connects veterinarians to the technology they require to manage their practices and gives them more time to spend with the animals in their care.
• In March 2022, Clinvet acquired a stake in RTI Labs, a CRO headquartered in South Dakota that specialized in food-producing animal preclinical trials. Complementing the spectrum of services provided by Clinvet's large animals' facilities in South Africa and Morocco, RTI's research facilities in the United States and expertise in infectious disease and immunology research enhanced Clinvet's presence and service offering in North America.

Segmentation of Veterinary CRO & CDMO Market-
By Animal Type -
• Companion
• Livestock Animals
By Application Type -
• Medicine
• Medical Devices
By Service Type -
• Discovery
• Development
• Manufacturing
• Packaging & Labelling
• Market Approval & Post-Marketing
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/veterinary-cro--cdmo-market/2333

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.